PAST EVENTS
PAST EVENTS
Clinical Rounds
Indy Hematology Clinical Rounds
January 21, 2026
In pursuant of promoting education in hematologic malignancies and disorders, Dr. Ruemu Ejedafeta Birhiray, President and CEO of Indy Hematology Education, Inc, in collaboration with Dr’s. Sumeet Bhatia and Catherine Socec, co- chair “Indy Hematology Clinical Rounds®” a quarterly CME education program.
This program is to create a tumor board forum where management of complex hematological cases can be discussed amongst physicians practicing mainly hematology malignancies and disorders, so that consistency is achieved for better outcomes
ASH Friday Satellite Symposia
Bringing Emerging Treatments to All Patients
December 5, 2025
A 3-hour symposium with presentations for community oncologists, preceding the ASH Annual Meeting.
Innovative immune effector therapies, including CAR T-cell and bi-specific antibody treatments, have transformed cancer care but remain largely inaccessible to community oncology practices. Our Network is dedicated to bridging this gap by establishing the necessary infrastructure, protocols, and training to safely and effectively administer these lifesaving therapies in community settings. By promoting equitable access, fostering clinical trial participation, and supporting diverse patient populations, we aim to reduce disparities and expand the reach of modern cellular therapies.
Reaching Clinical Trial Excellence
December 5, 2025
This symposium convenes oncology professionals, researchers, and policy advocates to explore the current challenges and strategic solutions in advancing inclusive excellence across the cancer research continuum. Attendees will engage with thought leaders discussing policy-aligned models for accountability, tools for building diversity plans into clinical trial design, and methods for standardizing demographic reporting in academic publications.
With a focus on practical implementation, the DRIVE Initiative offers a blueprint to help institutions, sponsors, and investigators align with regulatory guidance, such as the U.S. FDORA Act of 2022, while advocating for its broader international adoption. This is more than an academic discussion; it's a call to action for stakeholders committed to advancing equitable outcomes in cancer care and research.
Neurological Malignancies Symposia
Neurological Malignancies Symposium
August 23, 2025
Indy Hematology Education presents the Neurological Malignancies Symposium, a focused educational event designed to explore the evolving landscape of cancers affecting the central nervous system. This symposium will convene leading experts in neuro-oncology, hematology, and neurology to share current advances in the diagnosis, treatment, and supportive care of patients with primary and secondary neurological malignancies. Attendees will gain insight into the latest research on brain and spinal cord lymphomas, CNS involvement in hematologic malignancies, and emerging therapeutic strategies, including targeted agents and immunotherapies. The program emphasizes multidisciplinary approaches and practical guidance for managing these complex cases across both academic and community settings.
Indiana Oncology Nursing Society
August 23, 2025
Indy Hematology Education, Inc. is partnering with Oncology Nursing Society chapters to provide increased nursing education statewide. As a result, Indy Hematology Education, Inc. is planning our 2nd annual Indiana Oncology Nursing Society Symposium focusing on nursing education and the health of the nursing team to achieve improved patient outcomes.